Insider Trading Alert - TRLA, MFRM, MSFT, LNKD And BSX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 4, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $408.12 to $109,651,973.50.

Highlighted Stocks Traded by Insiders:

Trulia (TRLA) - FREE Research Report

Inkinen Sami who is Director at Trulia sold 5,800 shares at $33.18 on Feb. 4, 2014. Following this transaction, the Director owned 833,703 shares meaning that the stake was reduced by 0.69% with the 5,800-share transaction.

Flint Peter who is Chief Executive Officer at Trulia sold 9,200 shares at $33.38 on Feb. 4, 2014. Following this transaction, the Chief Executive Officer owned 1.5 million shares meaning that the stake was reduced by 0.61% with the 9,200-share transaction.

Levine Paul M. who is Chief Operations Officer at Trulia sold 11,490 shares at $33.18 on Feb. 4, 2014. Following this transaction, the Chief Operations Officer owned 36,068 shares meaning that the stake was reduced by 24.16% with the 11,490-share transaction.

The shares most recently traded at $32.50, down $0.68, or 2.11% since the insider transaction. Historical insider transactions for Trulia go as follows:

  • 4-Week # shares sold: 69,790
  • 12-Week # shares sold: 203,801
  • 24-Week # shares sold: 522,219

The average volume for Trulia has been 1.5 million shares per day over the past 30 days. Trulia has a market cap of $1.2 billion and is part of the technology sector and internet industry. Shares are down 6.35% year-to-date as of the close of trading on Tuesday.

Trulia, Inc. provides tools to research homes and neighborhoods for consumers through Web and mobile applications. The company, through its tools, also enables real estate professionals to market their listings. The company has a P/E ratio of 217.8. Currently there are 4 analysts that rate Trulia a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRLA - FREE

TheStreet Quant Ratings rates Trulia as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that net income has been generally deteriorating over time. Get the full Trulia Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mattress Firm (MFRM) - FREE Research Report

Murphy Kenneth E. III who is Executive Vice President at Mattress Firm sold 3,500 shares at $39.37 on Feb. 4, 2014. Following this transaction, the Executive Vice President owned 51,249 shares meaning that the stake was reduced by 6.39% with the 3,500-share transaction.

The shares most recently traded at $39.85, up $0.48, or 1.2% since the insider transaction. Historical insider transactions for Mattress Firm go as follows:

  • 4-Week # shares sold: 833
  • 12-Week # shares sold: 24,666
  • 24-Week # shares sold: 34,587

The average volume for Mattress Firm has been 285,300 shares per day over the past 30 days. Mattress Firm has a market cap of $1.3 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 7.57% year-to-date as of the close of trading on Tuesday.

Mattress Firm Holding Corp., through its subsidiaries, operates as a specialty retailer of mattresses, and related products and accessories in the United States. The company has a P/E ratio of 26.0. Currently there are 6 analysts that rate Mattress Firm a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MFRM - FREE

TheStreet Quant Ratings rates Mattress Firm as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow, generally higher debt management risk and disappointing return on equity. Get the full Mattress Firm Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Microsoft Corporation (MSFT) - FREE Research Report

Reller Tami who is EVP, Marketing at Microsoft Corporation sold 5,800 shares at $37.77 on Feb. 4, 2014. Following this transaction, the EVP, Marketing owned 455,974 shares meaning that the stake was reduced by 1.26% with the 5,800-share transaction.

The shares most recently traded at $36.31, down $1.46, or 4.02% since the insider transaction. Historical insider transactions for Microsoft Corporation go as follows:

  • 4-Week # shares sold: 5,800
  • 12-Week # shares sold: 79,800
  • 24-Week # shares sold: 40.6 million

The average volume for Microsoft Corporation has been 40.6 million shares per day over the past 30 days. Microsoft Corporation has a market cap of $302.8 billion and is part of the technology sector and computer software & services industry. Shares are down 2.83% year-to-date as of the close of trading on Tuesday.

Microsoft Corporation (Microsoft) develops, licenses, and supports software, services, and hardware devices worldwide. The stock currently has a dividend yield of 3.07%. The company has a P/E ratio of 13.5. Currently there are 11 analysts that rate Microsoft Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSFT - FREE

TheStreet Quant Ratings rates Microsoft Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Microsoft Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

LinkedIn (LNKD) - FREE Research Report

Sze David L who is Director at LinkedIn sold 6,250 shares at $215.35 on Feb. 4, 2014. Following this transaction, the Director owned 148,188 shares meaning that the stake was reduced by 4.05% with the 6,250-share transaction.

The shares most recently traded at $211.46, down $3.89, or 1.84% since the insider transaction. Historical insider transactions for LinkedIn go as follows:

  • 4-Week # shares sold: 6,250
  • 12-Week # shares sold: 48,087
  • 24-Week # shares sold: 79,337

The average volume for LinkedIn has been 2.0 million shares per day over the past 30 days. LinkedIn has a market cap of $21.9 billion and is part of the technology sector and internet industry. Shares are down 2.08% year-to-date as of the close of trading on Tuesday.

LinkedIn Corporation operates an online professional network. The company has a P/E ratio of 718.0. Currently there are 15 analysts that rate LinkedIn a buy, no analysts rate it a sell, and 14 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNKD - FREE

TheStreet Quant Ratings rates LinkedIn as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and disappointing return on equity. Get the full LinkedIn Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Boston Scientific (BSX) - FREE Research Report

Mario Ernest who is Director at Boston Scientific sold 10,000 shares at $13.19 on Feb. 4, 2014. Following this transaction, the Director owned 364,959 shares meaning that the stake was reduced by 2.67% with the 10,000-share transaction.

The shares most recently traded at $12.75, down $0.44, or 3.44% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 220,466
  • 24-Week # shares sold: 420,902

The average volume for Boston Scientific has been 11.0 million shares per day over the past 30 days. Boston Scientific has a market cap of $17.4 billion and is part of the health care sector and health services industry. Shares are up 6.91% year-to-date as of the close of trading on Tuesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Currently there are 7 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 13 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers